JPH0912915A - New coupler compound - Google Patents

New coupler compound

Info

Publication number
JPH0912915A
JPH0912915A JP7179587A JP17958795A JPH0912915A JP H0912915 A JPH0912915 A JP H0912915A JP 7179587 A JP7179587 A JP 7179587A JP 17958795 A JP17958795 A JP 17958795A JP H0912915 A JPH0912915 A JP H0912915A
Authority
JP
Japan
Prior art keywords
compound
group
formula
hydrogen peroxide
new coupler
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP7179587A
Other languages
Japanese (ja)
Inventor
Makoto Mizoguchi
誠 溝口
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dojin Kagaku Kenkyusho Kk
DOUJIN KAGAKU KENKYUSHO KK
Original Assignee
Dojin Kagaku Kenkyusho Kk
DOUJIN KAGAKU KENKYUSHO KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dojin Kagaku Kenkyusho Kk, DOUJIN KAGAKU KENKYUSHO KK filed Critical Dojin Kagaku Kenkyusho Kk
Priority to JP7179587A priority Critical patent/JPH0912915A/en
Publication of JPH0912915A publication Critical patent/JPH0912915A/en
Pending legal-status Critical Current

Links

Abstract

PURPOSE: To obtain a new coupler compound by oxidatively condensing a hydrogen donor, coloring in a higher wavelength and in absorbance than 4- aminopyrine, having high absorbance, suitable for microanalysis of hydrogen peroxide useful in clinical chemical test, etc. CONSTITUTION: This new coupler compound comprises and aminodiphenyl-based compound of formula I (R<1> to R<9> are each an alkyl, sulfo group, an alkoxy, a halogen, carboxyl, etc.; R<2> and R<5> may be bonded as they are or through a methylene chain; R<10> is a 1-5C alkyl which may contain sulfo group, carboxyl group, hydroxyl group, etc.). A compound of formula II among the compound of formula I is treated with a compound of formula III as a hydrogen donor in the presence of a peroxidase by hydrogen peroxide to form an oxidative condensate of formula IV and colored. The colored substance has the maximum absorption wavelength in the vicinity of 750nm.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は、新規カップラー化合物
に関し、特に臨床化学検査等で用いられる過酸化水素の
微量分析において、過酸化水素、ペルオキシダーゼの存
在下、TOOSなどの水素供与体と酸化的カップリング
して、色素を生じ、従来よりも高感度に測定できる新規
カップラーに関するものである。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a novel coupler compound, and in particular, in the microanalysis of hydrogen peroxide used in clinical chemistry tests and the like, in the presence of hydrogen peroxide and peroxidase, it is oxidative with a hydrogen donor such as TOOS. The present invention relates to a novel coupler that can be coupled to generate a dye and can be measured with higher sensitivity than before.

【0002】[0002]

【従来の技術】血液や尿などの生体成分中のさまざまな
物質の検出において、現在はそのほとんどが酵素的分析
法が用いられており、特にグルコースオキシダーゼ、コ
レステロールオキシダーゼ、ウリカーゼなどの各種酸化
酵素を用いる方法は、日常検査にも広く応用されてい
る。
2. Description of the Related Art At present, most of the enzymatic analysis methods are used for the detection of various substances in biological components such as blood and urine. In particular, various oxidases such as glucose oxidase, cholesterol oxidase and uricase are used. The method used is also widely applied to daily inspection.

【0003】酸化酵素によって生成する過酸化水素は、
カタラーゼやペルオキシダーゼの存在下に酸化発色基質
と反応させることによって容易に定量することができ
る。
Hydrogen peroxide produced by oxidase is
It can be easily quantified by reacting with an oxidative chromogenic substrate in the presence of catalase or peroxidase.

【0004】これらの酵素的分析法は、化学的反応を利
用する測定法と比較して、より特異的であり、また緩和
な条件で反応が完了することから、容易に自動化が可能
であり、今後益々普及していくものと思われる。
These enzymatic analysis methods are more specific than the measurement methods utilizing chemical reactions, and since the reaction is completed under mild conditions, they can be easily automated, It is expected that it will become more popular in the future.

【0005】現在、この分析法には、トリンダー法と呼
ばれる方法が多く用いられており、水素供与体とカップ
ラーとをペルオキシダーゼの存在下に過酸化水素によっ
て酸化縮合させて色素を形成させる方法が多く用いられ
ている。
At present, a method called the Trinder method is often used in this analysis method, and a method of oxidatively condensing a hydrogen donor and a coupler with hydrogen peroxide in the presence of peroxidase to form a dye is often used. It is used.

【0006】臨床化学検査において、検出感度を高くす
ることは、血液という貴重な検体を用いることや微量成
分を測定する必要から必然の要求である。そのことから
も現在使われている方法よりも高感度に測定できる方法
が求められている。
In clinical chemistry tests, it is inevitable to increase the detection sensitivity because of the use of a valuable sample called blood and the measurement of trace components. Therefore, a method that can measure with higher sensitivity than the method currently used is required.

【0007】また、これら公知の方法によって生じる色
素の波長は殆どのものが500nm〜600nmである
が、一方体液中に含まれるビリルビンや溶血によって生
じる吸収が紫外領域から530nm付近までの広範囲に
あるため、測定時に正の誤差を生じるおそれれがあり、
より高い波長領域で発色する方法が求められている。
Most of the wavelengths of dyes produced by these known methods are 500 nm to 600 nm, but the absorption produced by bilirubin and hemolysis contained in body fluids is in a wide range from the ultraviolet region to around 530 nm. , There may be a positive error during measurement,
There is a demand for a method of developing color in a higher wavelength region.

【0008】また、実際の測定時は、試薬を水溶液の状
態で使用するため、溶液状での試薬の安定性が求められ
ている。
Further, since the reagent is used in the state of an aqueous solution at the time of actual measurement, stability of the reagent in a solution is required.

【0009】現在、水素供与体としてはフェノールをは
じめ、TOOS、DAOS等多くの種類のものが使われ
ているが、カップラーとしては4−アミノアンチピリン
がほとんどのところで用いられており、その他の試薬が
使われていることはまれである。
At present, many kinds of hydrogen donors such as phenol, TOOS, DAOS are used, but 4-aminoantipyrine is used almost everywhere as a coupler, and other reagents are used. It is rarely used.

【0010】[0010]

【発明が解決しようとする課題】本発明の目的は、従来
のトリンダー法で用いるカップラーとして、水素供与体
と酸化縮合し、且つ波長、吸光度共に4−アミノアンチ
ピリンより高波長で発色し、且つ吸光度の高いカップラ
ーを提供するにある。
The object of the present invention is, as a coupler used in the conventional Trinder method, to oxidatively condense with a hydrogen donor and to develop color at a wavelength higher than that of 4-aminoantipyrine both in wavelength and absorbance, and in the absorbance. To provide high couplers.

【0011】[0011]

【課題を解決するための手段】上記の課題を解決するた
め鋭意研究を重ねた結果、得られた新規なカップラーは
次の一般式(1)で示されるアミノジフェニル系化合物
である。
Means for Solving the Problems As a result of intensive studies to solve the above problems, the novel coupler obtained is an aminodiphenyl compound represented by the following general formula (1).

【0012】[0012]

【化2】 (1) (式中、R1 〜R9 はアルキル基、スルホン酸基、アル
コキシル基、ハロゲン基、カルボキシル基、又は置換基
を有してもよいアルキル基であり、R2 とR5 はそのま
ま又はメチレン鎖を介して結合していてもよい。R10
スルホン酸基、カルボキシル基、水酸基又はアミノ基を
持っていてもよい炭素数1〜5のアルキル基をあらわ
す。)
Embedded image (1) (In the formula, R 1 to R 9 are an alkyl group, a sulfonic acid group, an alkoxyl group, a halogen group, a carboxyl group, or an alkyl group which may have a substituent, and R 2 and R 5 are the same. or a methylene chain which may be bonded via a .R 10 represents a sulfonic acid group, a carboxyl group, a hydroxyl group or an amino group having optionally also an alkyl group having 1 to 5 carbon atoms.)

【0013】これらの化合物は、従来のカップラーと同
じように水素供与体と酸化縮合反応する。
These compounds undergo an oxidative condensation reaction with a hydrogen donor in the same manner as conventional couplers.

【0014】例えば次の一般式(2)はFor example, the following general formula (2) is

【化3】 (2) 水素供与体である一般式(3)とEmbedded image (2) With the general formula (3), which is a hydrogen donor,

【化4】 (3) ペルオキシダーゼの存在下過酸化水素によって、一般式
(4)のような酸化縮合体を形成して発色する。
Embedded image (3) Hydrogen peroxide in the presence of peroxidase forms an oxidative condensate as represented by general formula (4) to develop color.

【化5】 (4)Embedded image (4)

【0015】この発色体は、4−アミノアンチピリンを
用いた発色体と異なり、極大吸収波長を750nm付近
に有する。この波長領域は、前記の生体マトリックスの
影響を受けないという意味で極めて有利であり、この測
定波長は光源としてレーザーが使用でき、高感度測定が
期待される。
This chromophore has a maximum absorption wavelength near 750 nm, unlike a chromophore using 4-aminoantipyrine. This wavelength region is extremely advantageous in that it is not affected by the biological matrix, and a laser can be used as a light source for this measurement wavelength, and high sensitivity measurement is expected.

【0016】また、極大吸収波長のモル吸光係数は、従
来法の2〜3倍を示し、高感度化という点でも有利であ
る。
The molar absorption coefficient at the maximum absorption wavelength is 2 to 3 times that of the conventional method, which is also advantageous in terms of high sensitivity.

【0017】さて、一般式(1)で示される化合物は、
次の一般式(5)
The compound represented by the general formula (1) is
The following general formula (5)

【化6】 (5) (式中R1 〜R10は前出一般式(1)と同じ意味を有す
る。)で示される化合物に酸性条件で亜硝酸ナトリウ
ム、亜鉛末を作用させて合成することができる。
[Chemical 6] (5) (wherein R 1 to R 10 have the same meaning as in the general formula (1) above) can be synthesized by reacting sodium nitrite and zinc dust under acidic conditions.

【0018】このようにして合成された一般式(1)で
示される本発明化合物の具体例を表1に、またその化合
物の融点、元素分析値及びpH7.4における過酸化水
素によるTOOSとのカップリング色素の極大吸収波長
λmax(nm) を表2に示す。
Specific examples of the compound of the present invention represented by the general formula (1) thus synthesized are shown in Table 1, and the melting point, elemental analysis value and TOOS with hydrogen peroxide at pH 7.4 of the compound. The maximum absorption wavelength λ max (nm) of the coupling dye is shown in Table 2.

【0019】[0019]

【表1】 [Table 1]

【0020】[0020]

【表2】 [Table 2]

【0021】[0021]

【実施例】次に実施例をあげて、更に具体的に本発明化
合物の製造法(実施例1〜3)及びそれを用いた定量方
法(実施例4,5)を説明するが、本発明はその要旨を
超えない限り以下の実施例に制約されるものではない。
EXAMPLES Next, the production method of the compound of the present invention (Examples 1 to 3) and the quantification method using the same (Examples 4 and 5) will be described in more detail with reference to Examples. Is not limited to the following examples as long as the gist thereof is not exceeded.

【0022】実施例1 化合物(A)の製造 N−メチルジフェニルアミン4.6gを塩酸20mlに
溶解し、撹拌しながら氷浴にて0℃に冷却し、5℃以下
で撹拌しながら、亜硝酸ナトリウム水溶液(2g/5m
l純水)を滴下した。滴下し終ったら更に5℃以下で1
時間撹拌を続け、その後純水100mlと塩酸100m
lとを加えた。更に10℃以下で撹拌しながら亜鉛末5
g加え、1時間撹拌を続けた。その後1Nの水酸化ナト
リウム水溶液でpH8に調節し、酢酸エチル200ml
を加えて抽出した。抽出液は硫酸マグネシウムで乾燥し
て濃縮し、溶離液として塩化メチルンを用いてシリカゲ
ルカラムにて目的物を分離した。分離された画分を濃縮
し、エーテル500mlに溶解後、撹拌しながら、塩酸
ガスを吹込んで、析出してきた塩酸塩を濾取し、乾燥し
て目的物2. 8gを得た。収率は47.5%であった。
Example 1 Preparation of Compound (A) 4.6 g of N-methyldiphenylamine was dissolved in 20 ml of hydrochloric acid, cooled to 0 ° C. in an ice bath while stirring, and sodium nitrite was stirred at 5 ° C. or lower. Aqueous solution (2g / 5m
1 deionized water) was added dropwise. After dropping, add 1 at below 5 ℃.
Stirring is continued for an hour, and then 100 ml of pure water and 100 m of hydrochloric acid
and 1 were added. Zinc powder 5 while stirring at 10 ° C or lower
g was added and stirring was continued for 1 hour. After that, adjust the pH to 8 with a 1N aqueous sodium hydroxide solution, and add 200 ml of ethyl acetate.
And extracted. The extract was dried over magnesium sulfate and concentrated, and the target substance was separated on a silica gel column using methyl chloride as an eluent. The separated fractions were concentrated and dissolved in 500 ml of ether, and then hydrochloric acid gas was blown into the solution while stirring, and the precipitated hydrochloride was collected by filtration and dried to obtain 2.8 g of the desired product. The yield was 47.5%.

【0023】TLC(シリカゲル、塩化メチレン):R
f=0.15。1 H−NMR(CD3 0D)σppm(TMS):3.
31(s,3H)、6.91〜7.40(m,9H)。 IR(cm-1):2904、2592、1602、15
16、1508、1350、1252、1134、75
0。
TLC (silica gel, methylene chloride): R
f = 0.15. 1 H-NMR (CD 30 D) σppm (TMS): 3.
31 (s, 3H), 6.91 to 7.40 (m, 9H). IR (cm -1 ): 2904, 2592, 1602, 15
16, 1508, 1350, 1252, 1134, 75
0.

【0024】実施例2 化合物(E)の製造 3,N−メチルジフェニルアミン3.9gを塩酸20m
lに溶解し、撹拌しながら氷浴にて0℃ に冷却した。
5℃以下で撹拌しながら、亜硝酸ナトリウム水溶液
(1.6g/3ml純水)を滴下し、滴下し終ったら更
に5℃以下で1時間撹拌を続け、その後純水80mlと
塩酸80mlを加え、更に10℃以下で撹拌しながら、
亜鉛末4g加え、1時間撹拌を続けた。その後1Nの水
酸化ナトリウム水溶液でpH8に調節し、酢酸エチル2
00mlを加えて抽出した。抽出液は硫酸マグネシウム
で乾燥して濃縮後、溶離液に塩化メチルンを用い、シリ
カゲルカラムにて目的物を分離した。分離された画分を
濃縮し、エーテル500mlに溶解後、撹拌しながら、
塩酸ガスを吹込んで、析出してきた塩酸塩を濾取し、乾
燥して目的物1.7gを得た。収率34.6%。
Example 2 Production of Compound (E) 3, N-methyldiphenylamine (3.9 g) was added to hydrochloric acid (20 m).
It was dissolved in 1 and cooled to 0 ° C. in an ice bath while stirring.
An aqueous sodium nitrite solution (1.6 g / 3 ml pure water) was added dropwise with stirring at 5 ° C or lower, and when the addition was completed, stirring was continued at 5 ° C or lower for 1 hour, and then 80 ml of pure water and 80 ml of hydrochloric acid were added, While stirring below 10 ° C,
Zinc dust (4 g) was added and stirring was continued for 1 hour. After that, the pH was adjusted to 8 with a 1N aqueous sodium hydroxide solution, and ethyl acetate 2
00 ml was added for extraction. The extract was dried over magnesium sulfate and concentrated, and then methyl chloride was used as an eluent to separate the desired product on a silica gel column. The separated fractions were concentrated, dissolved in 500 ml of ether and then stirred.
Hydrochloric acid gas was blown in, and the precipitated hydrochloride was collected by filtration and dried to obtain 1.7 g of the desired product. Yield 34.6%.

【0025】TLC(シリカゲル、塩化メチレン):R
f=0.22。1 H−NMR(CD3 OD) σppm(TMS):
2.30(s,3H)、3.29(s,3H)、6.7
2〜7.39(m,9H)。 IR(cm-1):2910、2592、1602、15
22、1350、1244、1115、792、72
6。
TLC (silica gel, methylene chloride): R
f = 0.22. 1 H-NMR (CD 3 OD) σppm (TMS):
2.30 (s, 3H), 3.29 (s, 3H), 6.7
2 to 7.39 (m, 9H). IR (cm -1 ): 2910, 2592, 1602, 15
22, 1350, 1244, 1115, 792, 72
6.

【0026】実施例3 化合物(J)の製造 N−スルホプロピルカルバゾールモノナトリウム塩5g
を塩酸20mlに溶解し、撹拌しながら氷浴にて0℃
に冷却した。5℃以下で撹拌しながら、亜硝酸ナトリウ
ム水溶液(1.5g/3ml純水)を滴下し、滴下し終
ったら更に5℃以下で1時間撹拌を続け、その後純水5
0mlと塩酸50mlを加えた。更に10℃以下で撹拌
しながら、亜鉛末を5g加え、1時間撹拌を続けた。そ
の後1Nの水酸化ナトリウム水溶液でpH8に調節し、
析出した水酸化亜鉛の沈殿を濾取した。濾液は濃縮し、
溶離液にクロロホルム/メタノール=8:2を用い、シ
リカゲルカラムにて目的物を分離した。分離された画分
を濃縮し、水/メタノール溶液で再結晶し、濾取したも
のを乾燥して目的物1.4gを得た。収率26.7%。
Example 3 Preparation of compound (J) 5 g of N-sulfopropylcarbazole monosodium salt
Is dissolved in 20 ml of hydrochloric acid and stirred in an ice bath at 0 ° C.
And cooled. Aqueous sodium nitrite solution (1.5 g / 3 ml pure water) was added dropwise with stirring at 5 ° C or lower, and when the addition was completed, stirring was continued at 5 ° C or lower for 1 hour, and then pure water 5
0 ml and 50 ml of hydrochloric acid were added. While further stirring at 10 ° C. or lower, 5 g of zinc dust was added and stirring was continued for 1 hour. After that, adjust to pH 8 with 1N sodium hydroxide solution,
The zinc hydroxide precipitate was collected by filtration. The filtrate is concentrated,
Chloroform / methanol = 8: 2 was used as an eluent, and the target product was separated on a silica gel column. The separated fractions were concentrated, recrystallized with a water / methanol solution, and the product collected by filtration was dried to obtain 1.4 g of the desired product. Yield 26.7%.

【0027】TLC(シリカゲル、クロロホルム/メタ
ノール=8.2):Rf=0.45。1 H−NMR(D2 O) σppm(TMS):1.7
2〜2.01(m,2H)、3.62(t,2H)、
7.02〜8.17(m,7H)。 IR(cm-1):2945、2877、1606、15
02、1469、1345、1280、1148、75
5、730。
TLC (silica gel, chloroform / methanol = 8.2): Rf = 0.45. 1 H-NMR (D 2 O) σppm (TMS): 1.7
2 to 2.01 (m, 2H), 3.62 (t, 2H),
7.02-8.17 (m, 7H). IR (cm -1 ): 2945, 2877, 1606, 15
02, 1469, 1345, 1280, 1148, 75
5,730.

【0028】実施例4 過酸化水素標準液による検量線
の作成 pH7.4の50mMリン酸緩衝液100mlにペルオ
キシダーゼ500単位とTOOS3.31mgを溶かし
たものを4個用意し、それぞれに化合物(A)を2.3
4mg、(E)を3.28mg、(J)を3.26mg
を溶かし、3種の発色溶液とした。それぞれの発色溶液
に対して、試験管a〜fを設け、それらの試験管に発色
溶液、及び過酸化水素標準液を以下のようにとった。
Example 4 Preparation of Calibration Curve Using Hydrogen Peroxide Standard Solution Four preparations were prepared by dissolving 500 units of peroxidase and 3.31 mg of TOOS in 100 ml of 50 mM phosphate buffer of pH 7.4, each containing compound (A). 2.3
4 mg, (E) 3.28 mg, (J) 3.26 mg
Was dissolved to obtain three kinds of color developing solutions. Test tubes a to f were provided for each color developing solution, and the color developing solution and the hydrogen peroxide standard solution were taken in these test tubes as follows.

【0029】 [0029]

【0030】各試験管を37℃の恒温槽に10分間浸け
た後、試薬盲検を対照にそれぞれの極大吸収波長での吸
光度を測定した。得られた値から作成した検量線を図1
に示す。
After immersing each test tube in a 37 ° C. constant temperature bath for 10 minutes, the absorbance at each maximum absorption wavelength was measured using the reagent blind test as a control. Figure 1 shows the calibration curve prepared from the obtained values.
Shown in

【0031】図1から1〜50μmの濃度範囲で各発色
試薬とも検量線が直線性を示すことがわかる。以上の結
果から本発明品の化合物全てが過酸化物質定量の際のカ
ップラーとして効果を奏することは明らかである。
From FIG. 1, it can be seen that the calibration curve shows linearity for each color forming reagent in the concentration range of 1 to 50 μm. From the above results, it is clear that all the compounds of the present invention have an effect as a coupler in the determination of a peroxide substance.

【0032】そのうち本測定において最も高い感度を示
した化合物Aについては、以下に定量の具体例を示す。
むろんこれは単なる例示であって、本発明がこれによっ
て限定されるものではない。
Regarding Compound A, which has the highest sensitivity in this measurement, specific examples of quantification are shown below.
Of course, this is merely an example, and the present invention is not limited thereto.

【0033】実施例5 化合物Aによる血清中のグルコ
ースの定量 50mMリン酸緩衝液(pH7.4)1mlにグルコー
スオキシダーゼ500単位、ペルオキシダーゼ500単
位、TOOS3.31mg及び化合物A2.34mgを
溶かし発色溶液とした。
Example 5 Determination of glucose in serum by Compound A 500 ml of glucose oxidase, 500 units of peroxidase, 3.31 mg of TOOS and 2.34 mg of Compound A were dissolved in 1 ml of 50 mM phosphate buffer solution (pH 7.4) to prepare a coloring solution. .

【0034】I)検量線の作成 グルコース200mgを100mlの純水にとかしたも
のをグルコース標準液とし、適宜希釈して実験に用い
る。
I) Preparation of Calibration Curve 200 mg of glucose dissolved in 100 ml of pure water is used as a glucose standard solution, which is appropriately diluted and used in the experiment.

【0035】試験管a〜dに以下に示す試薬をとった。The following reagents were taken in test tubes a to d.

【0036】 [0036]

【0037】各試験管を37℃の恒温槽に10分間浸け
た後、試薬盲検を対照に748.2nm吸光度を測定し
た。得られた値から作成した検量線を図2に示す。
Each test tube was immersed in a constant temperature bath at 37 ° C. for 10 minutes, and then the absorbance at 748.2 nm was measured using a reagent blind test as a control. The calibration curve prepared from the obtained values is shown in FIG.

【0038】その結果、グルコース濃度0〜200mg
/dlの範囲で良好な直線性を示した。
As a result, the glucose concentration was 0 to 200 mg.
Good linearity was exhibited in the range of / dl.

【0039】II)血清中のグルコースの定量 試験管に除蛋白した血清10mlをとり、上記発色溶液
0.1mlを加えて、37℃の恒温槽に10分間浸けた
後、試薬盲検を対照に748.2nmでの吸光度を測定
し、検量線と対比して血清中のグルコース濃度を求めた
結果は次のとおりであった。表3に示す。
II) Quantification of Glucose in Serum 10 ml of deproteinized serum was placed in a test tube, 0.1 ml of the above coloring solution was added, and the mixture was immersed in a constant temperature bath at 37 ° C. for 10 minutes. The results of measuring the absorbance at 748.2 nm and comparing the concentration of glucose in serum with the calibration curve were as follows. It is shown in Table 3.

【0040】[0040]

【表3】 [Table 3]

【0041】[0041]

【発明の効果】本発明のカップラー化合物をトリンダー
法のカップラーとして使用することにより、検出感度が
2〜3倍に向上し、必要サンプル量が少なくて済む。ま
た、測定波長が長波長側にあるため、溶血などによる測
定誤差を避けることができる。 また、光源としてレー
ザーが使用でき、より高感度の測定が期待される。
By using the coupler compound of the present invention as a coupler for the Trinder method, the detection sensitivity is improved by a factor of 2 to 3 and the required sample amount is small. Further, since the measurement wavelength is on the long wavelength side, it is possible to avoid a measurement error due to hemolysis or the like. Also, a laser can be used as a light source, and higher sensitivity measurement is expected.

【図面の簡単な説明】[Brief description of the drawings]

【図1】試薬A、E、JとTOOSの酸化縮合体の過酸
化水素濃度に対する検量線で、縦軸に極大吸収波長での
吸光度、横軸に過酸化水素濃度をとってある。但し、
●、○、■の記号はそれぞれ化合物A、E、Jを表わ
す。
FIG. 1 is a calibration curve with respect to the hydrogen peroxide concentration of the oxidative condensates of reagents A, E, J and TOOS, in which the vertical axis represents the absorbance at the maximum absorption wavelength and the horizontal axis represents the hydrogen peroxide concentration. However,
The symbols ●, ○, and ■ represent compounds A, E, and J, respectively.

【図2】試薬Aを用いたときのグルコース濃度に対する
検量線で、縦軸は748.2nmでの吸光度で、横軸は
グルコース濃度である。
FIG. 2 is a calibration curve for glucose concentration when Reagent A is used, in which the vertical axis is the absorbance at 748.2 nm and the horizontal axis is the glucose concentration.

───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.6 識別記号 庁内整理番号 FI 技術表示箇所 C07C 307/02 7419−4H C07C 307/02 309/24 7419−4H 309/24 309/29 7419−4H 309/29 C07D 209/88 C07D 209/88 219/08 219/08 G01N 31/00 G01N 31/00 M 31/22 122 31/22 122 33/52 33/52 C // C12Q 1/28 7823−4B C12Q 1/28 ─────────────────────────────────────────────────── ─── Continuation of the front page (51) Int.Cl. 6 Identification code Internal reference number FI Technical display location C07C 307/02 7419-4H C07C 307/02 309/24 7419-4H 309/24 309/29 7419- 4H 309/29 C07D 209/88 C07D 209/88 219/08 219/08 G01N 31/00 G01N 31/00 M 31/22 122 31/22 122 33/52 33/52 C // C12Q 1/28 7823− 4B C12Q 1/28

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】 次の一般式(1)、 【化1】 (1) (式中、R1 〜R9 はアルキル基、スルホン酸基、アル
コキシル基、ハロゲン基、カルボキシル基、又は置換基
を有してもよいアルキル基であり、R2 とR5 はそのま
ま又はメチレン鎖を介して結合していてもよい。R10
スルホン酸基、カルボキシル基、水酸基又はアミノ基を
持っていてもよい炭素数1〜5のアルキル基をあらわ
す。)で示されるアミノジフェニル系化合物よりなる新
規カップラー化合物。
1. The following general formula (1): (1) (In the formula, R 1 to R 9 are an alkyl group, a sulfonic acid group, an alkoxyl group, a halogen group, a carboxyl group, or an alkyl group which may have a substituent, and R 2 and R 5 are the same. or it may be bonded via a methylene chain .R 10 is a sulfonic acid group, a carboxyl group, an amino diphenyl represented by also have a hydroxyl group or an amino group represents an alkyl group having 1 to 5 carbon atoms.) A new coupler compound consisting of a series of compounds.
JP7179587A 1995-06-23 1995-06-23 New coupler compound Pending JPH0912915A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP7179587A JPH0912915A (en) 1995-06-23 1995-06-23 New coupler compound

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP7179587A JPH0912915A (en) 1995-06-23 1995-06-23 New coupler compound

Publications (1)

Publication Number Publication Date
JPH0912915A true JPH0912915A (en) 1997-01-14

Family

ID=16068345

Family Applications (1)

Application Number Title Priority Date Filing Date
JP7179587A Pending JPH0912915A (en) 1995-06-23 1995-06-23 New coupler compound

Country Status (1)

Country Link
JP (1) JPH0912915A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009084375A (en) * 2007-09-28 2009-04-23 Terumo Corp Oxidation coloring compound, reagent composition, and test implement
JP2009084374A (en) * 2007-09-28 2009-04-23 Terumo Corp Oxidation coloring compound, reagent composition, and test implement
WO2010053902A3 (en) * 2008-11-04 2010-07-08 Herbalscience Group, Llc Tryptase enzyme inhibiting aminothiophenols
WO2022210445A1 (en) * 2021-03-30 2022-10-06 保土谷化学工業株式会社 Compound having sulfonate group, and photoelectric conversion element using said compound

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009084375A (en) * 2007-09-28 2009-04-23 Terumo Corp Oxidation coloring compound, reagent composition, and test implement
JP2009084374A (en) * 2007-09-28 2009-04-23 Terumo Corp Oxidation coloring compound, reagent composition, and test implement
WO2010053902A3 (en) * 2008-11-04 2010-07-08 Herbalscience Group, Llc Tryptase enzyme inhibiting aminothiophenols
WO2022210445A1 (en) * 2021-03-30 2022-10-06 保土谷化学工業株式会社 Compound having sulfonate group, and photoelectric conversion element using said compound

Similar Documents

Publication Publication Date Title
US20170037248A1 (en) Fluorinated resorufin compounds and their application
CA2032154C (en) Method of high sensitivity luminescence analysis
EP0159870B1 (en) Method for the determination of mercapto compounds and reagent for use therein
JPH10130247A (en) Redox active compound and use thereof
JPH0764986B2 (en) New coloring reagent
JPS61138163A (en) Color developing coupler and use to measurement of hydrogen peroxide or other substance to be analyzed
US4396714A (en) N-Sulfoalkylaniline derivatives
US4824779A (en) Method for the determination of the reduced form of nicotinamide adenine dinucleotide
JPH0912915A (en) New coupler compound
EP0488756B1 (en) Oxidizable color producing reagent
JP2516381B2 (en) Method for quantifying hydrogen peroxide and reagent for quantifying the same
EP0140256B1 (en) Composition for examining urobilinogen
JP5231063B2 (en) Method for producing oxidation coloring compound
JPH07116382B2 (en) Water-soluble methylenebisdialkylaniline derivative and its salts, and composition for quantifying peroxides using the same
JP3036806B2 (en) Determination of trace components in body fluids
JPH0372619B2 (en)
JPH0423999A (en) Quantitative analysis of calcium
Mizoguchi et al. Water-soluble chromogenic reagent for colorimetric detection of hydrogen peroxide—an alternative to 4-aminoantipyrine working at a long wavelength
JP2001352999A (en) Oxidative chromogenic agent
JPS631939B2 (en)
JPH05262716A (en) Oxidizable color reagent
JPH05229993A (en) Triphenylmethane derivative
JPH0549500A (en) Method for decomposing hydrogen peroxide
JP2002159299A (en) Method for assaying substance
JP2000319238A (en) Chromogen for oxidizable color-developing reagent, determination method using the chromogen and determination reagent